Senjian Technology: G-BranchTM thoracoabdominal aortic stent graft system has obtained official registration approval from the Chinese National Medical Products Administration.

Senjian Technology Announces that on November 6, 2025, the G-BranchTM thoracoabdominal aortic endovascular stent graft system jointly developed by Professor Guo Wei's team at the First Medical Center of the Chinese People's Liberation Army General Hospital and our group has been officially registered and approved by the China National Medical Products Administration. This product is suitable for the treatment of thoracoabdominal aortic aneurysms involving the celiac trunk, superior mesenteric artery, and bilateral renal arteries, and can achieve complete intraluminal reconstruction of thoracoabdominal aortic aneurysms.